BARBARA PITTMAN: Open Payments
NPI 1003208497 · WAYCROSS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,783 in 81 payments from 17 companies in 2025. Trend: 2023 $1,369 · 2024 $1,572 · 2025 $1,783
Food & beverage: $1,684Education: $99
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 17 | $390 |
| ABBVIE INC. | 16 | $340 |
| Janssen Biotech, Inc. | 10 | $312 |
| Amgen Inc. | 14 | $252 |
| Novartis Pharmaceuticals Corporation | 7 | $142 |
| Mallinckrodt Hospital Products Inc. | 4 | $75 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| Organon LLC | 1 | $27 |
| Octapharma USA, Inc. | 1 | $26 |
Products named: Bimzelx, TREMFYA, RINVOQ, COSENTYX, SKYRIZI, OTEZLA, ACTHAR, EVENITY.
Industry payments across GA — which companies pay providers there.
